Oak Street Health (NYSE:OSH) Stock Rating Lowered by JPMorgan Chase & Co.

Oak Street Health (NYSE:OSH – Get Rating) was downgraded by investment analysts at JPMorgan Chase & Co. from an “overweight” rating to a “neutral” rating in a report issued on Thursday, The Fly reports. They presently have a $39.00 price objective on the stock, up from their prior price objective of $35.00. JPMorgan Chase & Co.‘s price objective points to a potential upside of 10.08% from the company’s current price.

A number of other equities research analysts have also recently weighed in on OSH. Piper Sandler cut Oak Street Health from an “overweight” rating to a “neutral” rating and dropped their price target for the company from $47.00 to $39.00 in a report on Wednesday, February 8th. Jefferies Financial Group cut Oak Street Health from a “buy” rating to a “hold” rating in a report on Thursday, February 9th. Morgan Stanley upgraded shares of Oak Street Health from an “equal weight” rating to an “overweight” rating in a research report on Monday, November 14th. Canaccord Genuity Group reduced their target price on shares of Oak Street Health from $32.00 to $27.00 in a research report on Wednesday, November 9th. Finally, William Blair lowered shares of Oak Street Health from an “outperform” rating to a “market perform” rating in a report on Thursday, February 9th. One equities research analyst has rated the stock with a sell rating, thirteen have assigned a hold rating and three have issued a buy rating to the company. According to data from MarketBeat, Oak Street Health currently has an average rating of “Hold” and an average price target of $32.67.

Get Oak Street Health alerts:

Oak Street Health Stock Performance

Shares of Oak Street Health stock opened at $35.43 on Thursday. The firm’s 50-day simple moving average is $28.04 and its 200-day simple moving average is $24.99. Oak Street Health has a twelve month low of $13.29 and a twelve month high of $35.65. The firm has a market cap of $8.61 billion, a P/E ratio of -15.61 and a beta of 2.32.

Insider Activity at Oak Street Health

In other Oak Street Health news, CFO Timothy M. Cook sold 1,480 shares of the business’s stock in a transaction that occurred on Thursday, February 2nd. The stock was sold at an average price of $28.49, for a total value of $42,165.20. Following the sale, the chief financial officer now owns 1,357,241 shares in the company, valued at approximately $38,667,796.09. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. In other Oak Street Health news, COO Brian Clem sold 5,000 shares of the business’s stock in a transaction that occurred on Tuesday, January 3rd. The stock was sold at an average price of $24.02, for a total value of $120,100.00. Following the sale, the chief operating officer now owns 546,337 shares in the company, valued at approximately $13,123,014.74. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, CFO Timothy M. Cook sold 1,480 shares of the company’s stock in a transaction that occurred on Thursday, February 2nd. The stock was sold at an average price of $28.49, for a total value of $42,165.20. Following the sale, the chief financial officer now owns 1,357,241 shares in the company, valued at approximately $38,667,796.09. The disclosure for this sale can be found here. In the last three months, insiders sold 624,890 shares of company stock worth $20,986,418. 11.40% of the stock is owned by company insiders.

Institutional Investors Weigh In On Oak Street Health

A number of institutional investors and hedge funds have recently made changes to their positions in the stock. Capital Research Global Investors raised its stake in Oak Street Health by 61.0% in the 1st quarter. Capital Research Global Investors now owns 11,852,080 shares of the company’s stock valued at $318,584,000 after acquiring an additional 4,491,941 shares during the period. Vanguard Group Inc. raised its stake in Oak Street Health by 5.8% in the 3rd quarter. Vanguard Group Inc. now owns 10,898,069 shares of the company’s stock valued at $267,221,000 after acquiring an additional 592,839 shares during the period. Eminence Capital LP raised its stake in Oak Street Health by 32.7% in the 2nd quarter. Eminence Capital LP now owns 3,615,541 shares of the company’s stock valued at $59,439,000 after acquiring an additional 891,114 shares during the period. Riverbridge Partners LLC raised its stake in Oak Street Health by 8.1% in the 3rd quarter. Riverbridge Partners LLC now owns 2,728,744 shares of the company’s stock valued at $66,909,000 after acquiring an additional 203,576 shares during the period. Finally, Spyglass Capital Management LLC raised its stake in Oak Street Health by 87.0% in the 4th quarter. Spyglass Capital Management LLC now owns 2,498,841 shares of the company’s stock valued at $53,750,000 after acquiring an additional 1,162,851 shares during the period. Institutional investors own 92.04% of the company’s stock.

About Oak Street Health

(Get Rating)

Oak Street Health, Inc, together with its subsidiaries, offers healthcare services to the patients in the United States. The company operates primary care centers for Medicare beneficiaries. As of December 31, 2021, it operated 129 centers in 19 states, including Illinois, Michigan, Pennsylvania, Ohio, and Texas.

Further Reading

• Get a free copy of the StockNews.com research report on Oak Street Health (OSH)
• Carvana Skidding On Revenue Decrease, Heavy Debt Burden
• What Are Consumer Staples Stocks?
• Is Rocky Brands Dividend A Good Fit For Your Portfolio? 
• Beyond Meat Stock Is Not Beyond Hope 
• Analysts Holding As Pfizer Waits On Two Phase 3 Studies

Receive News & Ratings for Oak Street Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oak Street Health and related companies with MarketBeat.com's FREE daily email newsletter.